Table 1.
Patient number | Gender | Age (years) | Height (cm) | Body weight (kg) | AHA | Surgery | Donor type | IST | Diagnosis (months PT) | Stenosis (%) | CTA after stent |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | Male | 29 | 174 | 72 | Yes | Single | Deceased | FK + MMF + prednisone | 6 | 90 | Yes |
2 | Male | 35 | 166 | 52 | Yes | Single | Deceased | FK + MMF + prednisone | 4 | 90 | Yes |
3 | Female | 35 | 164 | 48 | Yes | Single | Deceased | FK + MMF + prednisone | 5 | 90 | Yes |
4 | Male | 50 | 170 | 58 | Yes | CPKT | Deceased | CsA + MMF + prednisone | 7 | 85 | Yes |
5 | Female | 31 | 163 | 54 | Yes | Single | Deceased | FK + MMF + prednisone | 11 | 70 | Yes |
6 | Male | 40 | 165 | 50 | Yes | Single | Deceased | FK + MMF + prednisone | 4 | 70 | Yes |
7 | Male | 35 | 176 | 75 | Yes | Single | Deceased | FK + MMF + prednisone | 2 | 84 | No |
8 | Male | 32 | 170 | 68 | Yes | Single | Deceased | CsA + MMF + prednisone | 3 | 80 | No |
9 | Male | 47 | 170 | 72 | Yes | Single | Deceased | CsA + MMF + prednisone | 3 | 80 | No |
10 | Male | 25 | 173 | 68 | Yes | Single | Living related | FK + MMF + prednisone | 1 | 75 | No |
11 | Female | 16 | 160 | 45 | Yes | Single | Living related | FK + MMF + prednisone | 9 | 70 | No |
12 | Male | 27 | 170 | 60 | Yes | Single | Deceased | FK + MMF + prednisone | 4 | 70 | No |
13 | Male | 29 | 174 | 72 | No | Single | Deceased | FK + MMF + prednisone | 3 | Control | – |
14 | Male | 42 | 172 | 80 | No | Single | Deceased | FK + MMF + prednisone | 24 | Control | – |
15 | Male | 38 | 170 | 56 | No | Autotransplant | Deceased | No | 7 | Control | – |
16 | Male | 39 | 172 | 62 | No | Single | Deceased | FK + MMF + prednisone | 13 | Control | – |
17 | Female | 36 | 168 | 53 | No | Single | Living related | CsA + EC−MPS + prednisone | 8 | Control | – |
18 | Male | 40 | 165 | 50 | No | Single | Deceased | FK + MMF + prednisone | 9 | Control | – |
AHA: Antihypertensive agent; CPKT: Combined pancreas–kidney transplantation; IST: Immunosuppressive therapy; FK: FK506; CsA: Cyclosporine A; MMF: Mycophenolate mofetil; EC–MPS: Enteric–coated mycophenolate sodium; PT: Posttransplant; CTA: Computed tomography angiography.